{{Rsnum
|rsid=243847
|Gene=MMP2
|Chromosome=16
|position=55490086
|Orientation=plus
|GMAF=0.3343
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=MMP2
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 18.6 | 42.5 | 38.9
| HCB | 17.8 | 48.9 | 33.3
| JPT | 9.9 | 46.8 | 43.2
| YRI | 1.4 | 32.2 | 66.4
| ASW | 0.0 | 0.0 | 0.0
| CHB | 17.8 | 48.9 | 33.3
| CHD | 13.9 | 46.3 | 39.8
| GIH | 18.4 | 51.0 | 30.6
| LWK | 4.7 | 39.6 | 55.7
| MEX | 14.0 | 43.9 | 42.1
| MKK | 3.2 | 33.1 | 63.6
| TSI | 16.3 | 46.9 | 36.7
| HapMapRevision=28
}}{{PMID Auto
|PMID=21228795
|Title=Impact of LIMK1, MMP2 and TNF-? variations for intracranial aneurysm in Japanese population
}}

{{PMID|19454611|OA=1
}} Matrix metalloproteinase-2 polymorphisms and breast cancer susceptibility.

{{on chip | Affy GenomeWide 6}}